Compounds > colforsin
Page last updated: 2024-08-23

colforsin and Autoimmune Diabetes

colforsin has been researched along with Autoimmune Diabetes in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (50.00)18.2507
2000's2 (25.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, Z; Wang, J; Wang, Z; Yu, J; Zeng, Y; Zhang, Y1
Blake, CB; Smith, BN1
Becker, TC; Cao, W; Collins, QF; Collins, S; Daniel, KW; Floering, L; Lupo, EG; Robidoux, J; Xiong, Y1
Cohen, AJ; Fishman, JB; Silbiger, SR; Stoff, JS1
Buschard, K; Hansen, AK; Josefsen, K; Pedersen, C1
Casamitjana, R; Conget, I; Fernández-Alvarez, J; Ferrer, J; Gomis, R; Novials, A; Pujol-Borrell, R; Sarri, Y; Somoza, N1
Betteridge, DJ; Cooper, MB; Gasser, JA; Saggerson, ED; Tan, KC1
Beshay, E; Croze, F; Prud'homme, GJ1

Other Studies

8 other study(ies) available for colforsin and Autoimmune Diabetes

ArticleYear
A forskolin-conjugated insulin analog targeting endogenous glucose-transporter for glucose-responsive insulin delivery.
    Biomaterials science, 2019, Nov-01, Volume: 7, Issue:11

    Topics: Animals; Colforsin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Delivery Systems; Glucose; Glucose Tolerance Test; Glucose Transport Proteins, Facilitative; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Mice

2019
cAMP-dependent insulin modulation of synaptic inhibition in neurons of the dorsal motor nucleus of the vagus is altered in diabetic mice.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2014, Sep-15, Volume: 307, Issue:6

    Topics: Animals; Brain Stem; Brefeldin A; Colforsin; Cyclic AMP; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electric Stimulation; Female; gamma-Aminobutyric Acid; Glucose Transporter Type 4; Golgi Apparatus; Indinavir; Inhibitory Postsynaptic Potentials; Insulin; Male; Mice; Neural Inhibition; Protein Transport; Synaptic Transmission; Vagus Nerve

2014
p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis.
    The Journal of biological chemistry, 2005, Dec-30, Volume: 280, Issue:52

    Topics: Acetylcysteine; Adenoviridae; Animals; Cell Line, Tumor; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 1; Disease Models, Animal; Enzyme Inhibitors; Gene Silencing; Glucagon; Gluconeogenesis; Glucose; Glucose-6-Phosphatase; Hepatocytes; Imidazoles; Liver; Mice; p38 Mitogen-Activated Protein Kinases; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphoenolpyruvate Carboxykinase (GTP); Phosphorylation; Promoter Regions, Genetic; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Streptozocin; Trans-Activators; Transcription Factors; Transfection

2005
Defective glomerular beta-adrenergic signal transmission in spontaneously diabetic rats.
    The Journal of laboratory and clinical medicine, 1994, Volume: 124, Issue:2

    Topics: Animals; Blood Glucose; Colforsin; Cyclic AMP; Diabetes Mellitus, Type 1; Dinoprostone; Histamine; Isoproterenol; Kidney Glomerulus; Rats; Rats, Inbred BB; Rats, Mutant Strains; Receptors, Adrenergic, beta; Signal Transduction

1994
Neonatal stimulation of beta-cells reduces the incidence and delays the onset of diabetes in a barrier-protected breeding colony of BB rats.
    Experimental and clinical endocrinology, 1993, Volume: 101, Issue:3

    Topics: Animals; Animals, Newborn; Arginine; Colforsin; Diabetes Mellitus, Type 1; Glucose; Islets of Langerhans; Rats; Rats, Inbred BB; Stimulation, Chemical

1993
Human pancreatic islet function at the onset of type 1 (insulin-dependent) diabetes mellitus.
    Diabetologia, 1993, Volume: 36, Issue:4

    Topics: Adolescent; Colforsin; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Proinsulin; Protein Precursors; RNA, Messenger

1993
Altered cellular signalling and decreased platelet sensitivity to adenosine in insulin-dependent diabetic patients with proliferative retinopathy.
    Cellular signalling, 1993, Volume: 5, Issue:2

    Topics: Adenosine; Adenosine Diphosphate; Adenosine-5'-(N-ethylcarboxamide); Binding Sites; Blood Platelets; Cell Membrane; Colforsin; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Epoprostenol; Female; GTP-Binding Proteins; Humans; Middle Aged; Platelet Aggregation; Receptors, Purinergic; Signal Transduction

1993
The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.
    Clinical immunology (Orlando, Fla.), 2001, Volume: 98, Issue:2

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Autoimmune Diseases; Bucladesine; Cells, Cultured; Colforsin; Cyclic AMP; Diabetes Mellitus, Type 1; Dibutyryl Cyclic GMP; Disease Models, Animal; Drug Evaluation, Preclinical; Enterotoxins; Enzyme Induction; Female; Interferon-gamma; Interleukin-12; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred NOD; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Pentoxifylline; Phosphodiesterase Inhibitors; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rolipram; Tumor Necrosis Factor-alpha

2001